Mercury Systems, Inc. (MRCY) Earnings Call Transcript
August 18, 2026
Earnings Call Speaker Segments
Good afternoon, and thanks for being with us today. Joining me on this call are our Chairman and Chief Executive Officer, Bill Ballhaus, along with our Executive Vice President and CFO, Dave Farnsworth. Should you not have gotten a copy of the earnings press release that went out earlier this afternoon, it's available on our website, mrcy.com. The slide presentation we'll be referring to can be found in the investor relations section of the website, listed under events and presentations. If you'll turn to slide two, I want to remind everyone that forward-looking statements are part of today's presentation, including information about Mercury's financial outlook, future plans, objectives, business prospects, and anticipated financial performance; these forward-looking statements carry future risks and uncertainties that might cause our actual results or performance to differ materially. All forward-looking statements ought to be considered alongside the cautionary statements on slide two in the earnings press release as well as the risk factors contained in Mercury's SEC filings. We're also providing fiscal year 2028 reference points today, and those, together with our target profile, should not be interpreted as financial guidance and speak only as of today. These figures show what kind of financial shape the company might reach, assuming the elements just described play out — such as turning our backlog into revenue and booking more orders on top of what's already there. Whether we actually hit those reference points or that target profile could shift materially because of these elements. One more thing: alongside presenting results that follow generally accepted accounting principles, or GAAP, we'll go over a handful of non-GAAP financial measures on this call — namely adjusted income, adjusted earnings per share, adjusted EBITDA, and free cash flow. You can find a reconciliation of those non-GAAP metrics in an appendix attached to the slide presentation today, as well as in the earnings press release. At this point I'll pass things over to Mercury's Chairman and CEO, Bill Ballhaus. Please turn to slide three.
Thank you, Tyler. Hello, everyone, and I appreciate you joining this call to discuss our fourth-quarter and full-year FY 2026 results. Our Q4 performance exceeded expectations, marked by all-time highs in bookings, backlog, and revenue, along with our best EBITDA margin of the year and healthy free cash flow. Because of our strong execution and encouraging demand signals, we enter FY 2027 with improved visibility, and we are lifting our organic growth guidance. Today I'll cover three areas. To start, some opening comments on the business and our results. Then, an update on our four priorities: performance excellence, growth, margin expansion, and free cash flow. Next, I'll cover our outlook for fiscal 2027 and beyond. Following that, Dave will walk you through the financial details more thoroughly. Before getting into that, I'd like to express appreciation to our customers for collaborating so closely with us and for placing their confidence in Mercury to back their most essential programs. I also want to recognize the Mercury team for their hard work and commitment to providing high-performance processing and making mission dominance possible for the war fighter at the edge. Let's move to slide three. In Q4, we delivered robust organic growth together with an improvement in margins. We achieved a record $660 million in bookings — an increase of 93.1% compared with the same period last year, and nearly twice what we booked in our previous record quarter. Our book-to-bill ratio was 2.3. We ended with backlog at an all-time high above $1.9 billion, and our next 12-month backlog also set a record at $1 billion. Revenue hit a record $290 million. Adjusted EBITDA came to $49 million, giving us an adjusted EBITDA margin of 16.7%. Free cash flow totaled $29 million. When Q4 closed, net debt stood at $227 million, down 19.5% compared with the prior year. These numbers reflect how we keep concentrating on the four priority areas. Among the highlights, strong performance throughout our wide-ranging portfolio produced FY 2026 organic revenue growth of 7.9% along with adjusted EBITDA growth of 25.7%. Backlog and next 12-month backlog each grew year-over-year, by 38.4% and 23.3%, respectively. For the entire year, our adjusted EBITDA margin improved by 217 basis points compared with the prior year. We also kept advancing on the things that drive free cash flow: net working capital came down 4% versus a year ago, even as revenue increased 7.9%. If you'd go to slide five, we'll begin with our four priorities. The first one is performance excellence, and there we're concentrated on executing well on development programs, serving our customers throughout our portfolio, and achieving efficient scale-up on many programs that are moving into higher-volume production. In Q4, we increased output on quite a few programs and delivered our highest quarterly revenue ever. Overtime revenue came in at a 23.6% increase compared to the same period last year — our best showing in 15 quarters. A big part of that came from receiving material, which tells us our supply chain is lining up better with the organic growth picking up in multiple parts of the business. On the domestic side, which makes up about 85.8% of FY 2026 revenue, we saw 13% organic growth year-over-year. With solid bookings, a record backlog, and the strides we've made in scaling efficiently, organic growth has landed above what we'd expected for FY 2026, and we're looking at even stronger growth ahead, which I'll get into in a moment. Beyond those solid results, our efforts continue on expanding capacity, integrating additional automation, and merging smaller sites as we pursue greater scalability and efficiency. One item I'd call out: we recently made public a strategic partnership with Palantir, focused on applying AI software to bolster materials planning and manufacturing operations, which should help us boost backlog conversion and deliver essential technologies to the war fighter. This is one of many actions we've undertaken, along with prior investments across various critical technology initiatives designed to grow our capacity for swiftly providing key capabilities to our customers. Please go to slide six. Moving on to priority two, driving organic growth. We believe short-term organic growth is going to be driven by increased volume across programs already in production, as well as the ongoing migration of several development programs into the production phase. Beyond that, we anticipate possible additional gains tied to potential tailwinds involving stronger customer demand and greater quantities across a wide range of production programs in our portfolio. Lastly, we're excited about new development programs and the potential production volume associated with those wins; during Q4, we recorded a record quarter with $660 million of bookings, which generated record fiscal year bookings of $1.5 billion, representing a 49.8% increase year-over-year, together with a book-to-bill of 1.57 for the year. We're entering FY 2027 and FY 2028 with a record total backlog that's nearing $2 billion, which also gives us better visibility. One thing worth noting: our revenue coverage from backlog over the next 12 months is above what we'd normally see, because several of the larger orders we booked recently bundled quantities together that, under other circumstances, would have appeared as bookings and revenue recognized in FY 2027. Q4 bookings strength showed up across the board, with meaningful production awards spanning our products and solutions in Common Processing Architecture, effectors, airborne applications, space, and missile defense. The standout: CPA bookings hit their highest level of any quarter we've had, which we see as a sign of how differentiated our CPA solutions are and which strengthens our confidence in the growth potential for this area. During this period, we also recorded substantial bookings tied to locking in memory capacity for upcoming manufacturing needs on several sophisticated defense systems. Additionally, the benefits of the defense spending climate are starting to materialize, resulting in multiple long-term agreements from customers. With global defense budgets rising and domestic objectives in play, we keep anticipating stronger need across various initiatives in our offerings, such as space, munitions, missile defense, and our Common Processing Architecture. I stay hopeful that these possible favorable market forces could boost our demand landscape, provided funding gets directed toward specific program priorities for our customers throughout the coming quarters and further ahead. Now, please move to slide seven. Now turning to priority three, margin expansion. As we work to move toward the adjusted EBITDA margin profile we're aiming for, in the low to mid-20s, our attention is on these drivers: expanding backlog margin as we convert backlog with lower margins and add new bookings that fit our target margin profile, continuing initiatives to simplify, automate, and optimize operations further, and driving organic growth so positive operating leverage increases. Gross margin for FY 2026 came in at 28.6%, up 70 basis points year-over-year, which matches what we expected — that average backlog margin will keep rising as we convert legacy backlog with lower margins and bring in new bookings we believe will align with our target margin profile. Looking at fiscal 2026, our operating expenses came in below the prior year when measured against revenue. That shows how we've stayed committed to finding efficiencies and making positive operating leverage possible while pushing organic growth faster. For the whole year, adjusted EBITDA margin landed at 15.3%, right in line with what we had expected, and that's an increase of 217 basis points compared with last year. If you'd turn to slide eight. And now the last item, priority four, which is free cash flow conversion. Progress continues on what drives our free cash flow, particularly networking capital, sitting at roughly $431 million, which is a decrease of $18 million from a year ago. Free cash flow for the full year reached $68 million, leaving us with net debt of $227 million when Q4 closed, and we brought that down by $55 million versus the prior year.
We think the progress we keep making in how we run programs, plan for demand, and manage our supply chain — plus the flexibility that comes from a strong balance sheet — puts us in a good spot to generate organic growth and take advantage of any extra market tailwinds that might emerge. Take a look at slides nine and 10; as we head into FY 2027, our backlog is at a record level, and we think visibility across multiple years has improved. We've lifted our expectations for organic growth. That reflects the strength of our team's execution, our strategic positioning — which in our view aligns closely with priority global defense areas — and a supportive market environment, with the addressable market projected to grow at a 9.9% compound annual rate, as we describe in more detail in our Form 10-K filing. Looking ahead, in line with our goal of outpacing the market on organic growth and taking into account this attractive market outlook, we're increasing our targeted organic revenue growth to low double digits, while maintaining our targeted adjusted EBITDA margin in the low to mid-20s and our targeted free cash flow conversion at 50%. Given how well we did in FY 2026, we believe we're in a solid position to eventually hit that larger goal; looking ahead to FY 2027, our expectation is that revenue growth will come close to double digits compared with the prior year, with total revenue nearing $1.1 billion. Our forecast calls for Q1 revenue to be the softest quarter of the year while still climbing at a high single-digit rate versus a year earlier, and then revenue should build as the year progresses. On the bottom line, we're looking for an adjusted EBITDA margin in the high teens, along with adjusted EBITDA nearing $200 million across the full year, which works out to growth of almost 30% year-over-year. As the year unfolds, we expect that adjusted EBITDA margin will broadly rise, and for Q1 the adjusted EBITDA margin should come in around the same level as Q1 FY 2026. Because demand has risen, we intend to put focused money into stock, automation, and plant optimization so that we can grow organically; across the whole year, we forecast that FY 2027 free cash flow conversion will land under our 50% goal, near 35%, and we anticipate that free cash flow during the second half will exceed what we see in the first half. Owing to scheduling, Q1 is usually the quarter with the weakest cash flow for us, and we expect it to show a bigger outflow than usual, largely because we are receiving materials to back our growth projections along with the defense spending tailwinds that lie ahead. With the backlog at an all-time high and what we see as better multi-year visibility reaching past FY 2027, we're offering extra reference points for FY 2028. Under our first take on FY 2028, the reference point for organic growth at the top line sits in the low double digits. As for adjusted EBITDA margin, it lands at the low end of our target margin profile, and for free cash flow, a move back toward conversion consistent with our target. Also, while our projections for fiscal 2027 and fiscal 2028 do account for a small number of favorable developments already reflected in confirmed orders, they leave out what could come from further favorable developments that might arise in various production programs throughout our portfolio — among them Common Processing Architecture, effectors, airborne applications, space, and missile defense. On top of that, this guidance excludes any gains stemming from the Palantir collaboration we went over earlier, as well as from other automation efforts across the company designed to improve how we convert backlog. In our view, benefits along those lines might deliver better organic growth in adjusted EBITDA margin, which would amount to potential upside relative to our outlook. To wrap up, given our favorable momentum, record backlog, and enhanced visibility following a robust FY 2026, we're eager to perform well for our customers, support high-performance processing and mission dominance for the war fighter at the edge, and capitalize on what we see as a major value creation opportunity ahead of us; with that, I'll hand things over to Dave to go through the financial results for the quarter and fiscal year, and I'm happy to take your questions. Dave?
Thanks, Bill. The results we posted for the fourth quarter show we're still making headway on our objective of generating organic growth while widening margins. Reaching the profile we're aiming for will take more effort, but the strides we've taken give us confidence, and we anticipate carrying this momentum forward. Now, if you'd go to slide 11, you'll see the specifics of our fourth quarter results. Bookings hit a record of roughly $660 million for the quarter, producing a book-to-bill of 2.28. Backlog reached a record above $1.9 billion, an increase of $540 million, or 38.4%, versus a year ago. Fourth quarter revenues came in at a record of just about $290 million, an increase of roughly $17 million, or 6.1% on an organic basis, against the prior year. Gross margin in the fourth quarter was 30.6%, versus 31.0% in last year's comparable quarter. The fourth quarter gross margin was mainly a function of our program mix along with higher net EAC change impacts of about $4 million relative to the prior year. For the fiscal year, net EAC change impacts came in lower than they did in the prior fiscal year. As we mentioned before, we anticipate gross margin performance will improve over time as the average margin in backlog gets better and as we keep concentrating on simplifying, automating, and optimizing operations. We anticipate average backlog margin will keep rising as we work through lower margin backlog and add new bookings that we expect to align with the margin profile we're targeting. Operating expenses rose by roughly $13 million compared with a year ago. When it comes to the uptick we saw in operating expenses, the biggest contributors were higher SG&A and R&D costs, which came in at around $10 million and $4 million, respectively. The primary forces driving those gains were expenses tied to compensation, including stock-based compensation. Working in the opposite direction were reduced acquisition costs and other associated expenses, plus amortization of intangible assets, which together added up to roughly $2 million. On a GAAP basis, net income and earnings per share for Q4 landed at about $1 million and $0.01, respectively, compared with GAAP net income and EPS of approximately $16 million and $0.27, respectively, in the same quarter a year ago. Adjusted EBITDA for the fourth quarter stood at approximately $49 million, down from $51 million in last year's comparable quarter. For the quarter, adjusted EBITDA represented 16.7% of revenue, compared with 18.8% during the same period a year earlier. Adjusted earnings per share for Q4 stood at $0.37, down from $0.47 the previous year. Free cash flow during the fourth quarter totaled roughly $29 million, against $34 million a year ago. Turning now to slide 12 and our results for the entire year: fiscal 2026 bookings hit approximately $1.5 billion, which is $514 million higher — a gain of almost 49.8% — setting a record for bookings. Book-to-bill came in at 1.57, driving record backlog that exceeded $1.9 billion, an increase of 38.4% over fiscal 2025. As for fiscal 2026, revenue came in at $984 million. Compared with the prior fiscal year, that represents a gain of about $72 million, or 7.9%. Gross margin for fiscal 2026 was 28.6%. In fiscal 2025, the gross margin figure was 27.9%, so this is about 70 basis points greater. Lower manufacturing adjustments and smaller net EAC change impacts than in the earlier year were the primary factors behind the fiscal 2026 gross margin improvement. In fiscal 2026, operating expenses rose roughly $7 million, or 2.5%, relative to the prior year. Approximately $21 million in additional selling, general and administrative expenses accounted for most of this increase. The main cause was higher compensation expense, with $10 million of that amount related to stock compensation. On the other side of the ledger, we saw decreases in two areas: research and development costs, along with amortization of intangible assets, each of which came down by $8 million and $4 million, in that order. When you look at our operating expenses as a percentage of revenue, there was a 150 basis point decline compared with the same period last year. What's driving that is the savings we're getting from the workforce reductions we talked about earlier — those were designed to bring our staffing in line with a production mix that's now weighted more heavily toward higher-end offerings, and that's giving us improved operating leverage. Turning to fiscal 2026, our GAAP net loss was about $30 million, with loss per share of $0.50. For the prior year, the figures were a GAAP net loss of approximately $38 million and loss per share of $0.65. When comparing this year to last, the main driver behind the boost in earnings was stronger gross margins, though that was partially counterbalanced by a rise in operating expenses. For fiscal 2026, adjusted EBITDA came to $150 million — a figure that exceeds the previous year by $31 million, equivalent to 25.7%. Measured against revenue, our adjusted EBITDA margin landed at 15.3%, which represents 217 basis points of expansion over the prior year. This improvement reflects both tighter execution and stronger operating leverage during the current period when set against the earlier one. Adjusted earnings per share for the fiscal year reached $1.06, up from $0.64 in the previous fiscal year. Free cash flow during fiscal 2026 amounted to roughly $68 million, compared with $119 million a year earlier. On slide 13, you can see Mercury's balance sheet covering the past five quarters. We ended the fourth quarter with $214 million in cash and cash equivalents. Compared with the same period last year, that represents a decrease of about $95 million. The primary driver of that decrease was a $150 million payment on our revolving credit facility. Working partly against that decrease was $68 million in free cash flow that we generated during this fiscal year. Billed receivables were down sequentially by about $26 million, which works out to 27.6%, and during the fourth quarter, unbilled receivables increased by $16 million. When you look at the decrease we saw in total receivables on a net basis, it comes down to the added momentum from executing the programs our customers rely on, and that is what fueled how cash moved for us in fiscal 2026. On inventory, we saw a sequential uptick of about $5 million. The main driver there was raw materials, since we brought material into our facilities to back the higher point in time revenue across a number of the company's production programs. Turning to prepaid expenses and other current assets, those fell by around $22 million versus the previous quarter. Most of that decline traces to our shareholder settlement, which was approved and wrapped up in the fourth quarter, and normal operating expenses offset part of it. On the payables side, we saw a decrease of roughly $13 million versus the prior quarter, driven mostly by the schedule on which we remitted money to vendors. Accrued expenses were down about $36 million compared with the previous quarter, primarily as a result of the shareholder settlement that got approved and wrapped up during Q4. What we owed under our factoring facility shrank by approximately $14 million quarter-over-quarter, chiefly due to the timing of incoming customer payments that were owed back to our counterparty. Accrued compensation, meanwhile, increased by around $18 million relative to the prior quarter, largely on account of our incentive compensation plans. Our deferred revenues went up roughly $23 million from one quarter to the next, and the main reason was that we hit more milestone billing events in that timeframe. When you look at net working capital, it declined by roughly $18 million versus the same quarter last year, which works out to 4%. As we've mentioned previously, because our net working capital keeps getting better year after year, we were able to pay $150 million toward our revolver in Q4. That's further evidence of how far we've come in turning around the multi-year pattern of net working capital increases — we're now down about $229 million, or 34.8%, from the highest point, which came in Q1 fiscal 2024. We feel our solid financial position provides ample room to pursue and seize possible favorable market conditions. Turning now to slide 14 for cash flow: free cash flow during Q4 reached roughly $29 million, versus $34 million during the same period last year. We expect that ongoing gains in how well we execute programs, ship hardware, and structure payment timing will keep driving working capital lower; to wrap up, we're happy with how Q4 and fiscal 2026 turned out, along with the greater predictability we're seeing across the business. Our view is that if we keep delivering against those four areas we've made our main priorities, we'll generate both top-line growth and better profits, and on top of that we should see margins widen further and more of our earnings turn into cash — all of which shows what this company can create in value over the long haul. With that said, I'll hand things back to Bill now.
Thanks, Dave; with that, operator, please proceed with the Q&A.
Hi there, and thanks to Bill, Dave, and Tyler. Great numbers. Solid guidance.
Hi, Peter — appreciate it.
Hey, so Bill, maybe you could offer a brief remark on how 2027 is shaping up — meaning you'll keep seeing margin improvement as the year goes on, and clearly much stronger in the back half. Is that purely pricing in backlog? Is it mix? Or is it simply volume leverage? How would you describe what you're seeing when it comes to margin expansion?
Yeah. Thanks, Peter, for the comments. I'd call it a continuation of what we've been discussing regarding how our backlog margin progresses, as we have continued — and mostly, as we've said from the start, once we work our way through FY 2027, this dynamic won't be something we talk about anymore. What we see early in the year is lower margin backlog burning down, with margins rising as we move through the year, so that by the time we reach the end of the fiscal year, we expect to be operating in line with our target profile. So, putting the whole picture together and looking at how we exited the quarter with a really strong quarter, we've set ourselves up with great visibility for 2027. We increased our target outlook. We now have increased line of sight to reaching our target profile, and we discussed how we expect to get there through FY 2027 and FY 2028. I think it's simply a continuation of the positive story we've been communicating.
Understood. Real quick, I want to ask about the bookings. This quarter you landed the biggest single award. What I'm wondering is whether any customer program has reached 10% of backlog at this point, and whether you have anything to say about how CPA bookings ended up, I suppose, across the full year. Thanks.
Yeah, no. CPA closed out really well. Bookings for CPA hit a record this year, and once more, that tracks the path we described a few years back when we discussed returning to production and reaching full rate of production. Once we got there and performed well, a whole set of opportunities would become available, and that is exactly what we are seeing today. If I were to sum up how bookings went for the year, I wouldn't attribute it to a single area or program. It was wide-ranging throughout the business. We posted a record quarter; it came in at almost twice our previous record quarter from the quarter before, and it truly shows the robust outlook we have companywide for solid organic growth. So, genuinely broad based, and it's exciting to witness those kinds of demand signals throughout our whole portfolio.
Understood. I'll rejoin the line later on. Appreciate it, everyone.
Thank you.
Yes, hello and good afternoon to Bill, Dave, and Tyler. I'd like to dig deeper into that fiscal 2027 revenue outlook; it's higher than what you've clearly suggested is your normalized organic growth expectation. Could you perhaps explain, Bill, how we should view this as capturing some of those recent large framework agreements, the UCA agreements that have been put in place on the missile side, and possibly European defense? To what extent does it account for expansion in a few of these other areas rather than simply a somewhat improved view of the core business?
Yes, I'd say it's the second one. Once more, demand has risen, bookings and backlog are at record levels, and this mirrors what we observe across the portfolio broadly. We've spoken about the tailwinds present in the market, and right now very few of those tailwinds show up in our outlook. If you assemble what's driving our outlook, one of the largest jumps this quarter came from growth in our next 12 months backlog. That's roughly $1 billion; therefore the visibility we have on FY 2027 and moving into FY 2028 is extremely high. Our coverage on FY 2027 is extremely high. However, plenty of things have not been folded into that outlook. The tailwinds we mentioned regarding higher production quantities, and so on, that sit in our pipeline, mirroring conversations underway with multiple customers in areas such as CPA, effectors, munitions, space, missile defense — none of that appears in our outlook. We continue to see substantial potential in those areas. As we've stated previously, should any of those turn into firm bookings, it might have a substantial impact on our outlook. Yet none of that has been factored in thus far. In addition, we haven't factored in any gains in our backlog conversion, and we currently have many efforts underway throughout the enterprise to enhance our backlog conversion; over the past year especially, you've witnessed how, relative to our outlook, we managed to enhance backlog conversion and surpass our outlook. We have a great deal underway at present that isn't incorporated into our outlook, including the Palantir agreement we announced and a number of automation efforts we've implemented so that we can grow our scale and scale efficiently. So I'd say very little of the tailwinds we've discussed has been incorporated into our current outlook.
Yeah. Bill, I'd like to ask a follow-up about that Palantir deal, if that's alright. Should we view it primarily as something that boosts EBITDA, or as a genuine opportunity — or could it also move the top line? Any extra specifics you can share, plus timing for how it folds into the business, and how we ought to model its effect on the financials.
Yeah. We're at an early stage with it, though from what we've observed thus far, I believe the potential is substantial when it comes to the gains we can generate by putting their technology to work. This DoW-sponsored effort has a single aim: delivering the advantages of our technology and capabilities to the war fighter, and doing so more quickly — that's what the initiative is centered on. Obviously, alongside that, we'd likely see revenue grow in connection with the deliveries. And along with that, margin expansion, and we've discussed the favorable operating leverage that comes as we grow the top line and speed up its growth. And then, similarly, cash improvements follow. Those are the main KPIs that we believe could be affected favorably through the Palantir relationship. Still, we're early in, and once results come in, we'll certainly share updates as we get them.
Thanks, Bill.
Hello, and congratulations from me too on such strong bookings this quarter. I'd like to get a clearer picture of how that much backlog coverage and visibility shapes what you can do with production efficiency, the supply chain, and utilization of facilities.
It's a huge advantage. A few things stand out about what our bookings results this year have done. Clearly, with our next 12-month backlog higher and the added visibility, we feel very confident about our outlook and our capacity to deliver on it. When you consider how much our backlog has grown compared with last year, the portion extending beyond the coming twelve months has grown even more. That gives us a strong capacity to see ahead, to plan, to coordinate with our suppliers, and to seek the best outcomes across the entire life cycle. It simply provides us with many degrees of freedom to pursue optimization and push for better results in our performance. We have real confidence in the solid base we've built, in our capacity to raise our forecast for organic growth, and in the improved visibility we now enjoy into the business over the years ahead.
Understood. Regarding how we're allocating capital — I'm aware you reduced a portion of the revolver balance. You've improved at unlocking working capital. Which priorities rank higher for free cash flow during this quarter, and also over the year ahead? Thanks.
Right. What we've been concentrating on is steadily lowering net debt and steadily lowering our leverage. Jonathan, as I've told you on numerous occasions, essentially all of our attention — 99.99% — goes toward the organic value creation chance sitting right in front of us. For that reason, given the robust indicators we're observing, we'll direct certain focused investments into inventory, into facilities, into CapEx, which will assist us in scaling, growing, and speeding up organic growth. Yet what matters most to us at present when it comes to generating value is seizing the favorable market conditions we're seeing.
Thanks.
Hey there, everyone. Kyle here, filling in for Sheila. Appreciate you fielding my question, and congratulations on a strong quarter — it's wonderful to watch those bookings materialize.
Thank you, Kyle.
I was just going through the 10-K, and the five-year market outlook you're presenting there is genuinely interesting. I'm curious, when it comes to the growth outlook for 2027 and 2028, is there anything that's kind of holding growth back, whether that's budget certainty — you made some remarks about strategic inventories — or anything else? Or am I just trying to get a sense of whether this reflects conservatism, or whether there's something near term that's kind of capping what growth might look like across a multi-year period.
Yeah. I'd say we tend to frame it less as constraints and more as the natural evolution of our portfolio, as we've shifted from a heavy concentration of development programs into low rate production, medium rate production, and higher rate production; along with that, you see the organic growth of the business rise in the way you'd expect, going from low single digits to mid-single digits, getting close to double digits, and then reaching double digits. While we've been moving through that evolution, we're also working on better backlog conversion so we can overdrive our performance outlook. Beyond that, there are a number of tailwinds in the market we're focused on that also aren't factored into that outlook. Our view is that this outlook aligns with the progression we've seen in the portfolio, and I think there are plenty of opportunities for us to outperform and overdrive that outlook.
All right, that helps. To build on that, could you talk about what you're assuming in the free cash flow guidance for the coming year regarding working capital and CapEx, since there's an increase in Q4 and the release mentioned some additional spending there? And along those lines, could you also share your thoughts on how healthy the supply chain is, which drove such a strong overtime revenue figure this quarter? Thanks, guys.
I'll have Dave address the CapEx. First, I appreciate that you pointed out the rise in our overtime revenue. For a number of quarters, we've talked about how we're trying to bring our supply chain in line with margins on our deliveries, giving us more and more flexibility to optimize across our plants and boost backlog conversion. Over the past few quarters, we've seen real progress there, and we expect that to keep going. Dave, would you like to speak to the CapEx side?
Right. I'd say the way to think about it is that our capital expenditures should come in level compared with the prior year. What we're putting our attention on is what Bill mentioned when he spoke earlier, and what he's also raised in previous quarters — namely, genuinely making our operations as efficient as possible, looking at it both in terms of capacity and in terms of footprint, while simultaneously raising how much automation we use going forward. Something we've discussed across the past 2 quarters, and which you've observed, is that our feelings about the balance sheet's position are positive, and we believe we have the wherewithal to push somewhat harder with our suppliers and to obtain materials sooner, which lets us cut down the typical lead time associated with some of that work. Given the visibility that's available to us, and with the backlog that's out there, we think that represents a genuinely strong deployment of our capital.
Hello there, and good evening, everyone. Rocco here, filling in for Seth.
Hello, Rocco.
Our domestic sales had a solid year, climbing 13%. International sales, though, fell roughly 15%. Is there something in the international market creating headwinds we should mention, or was it simply that domestic demand absorbed more capacity this year?
Yeah. Thanks a lot for asking. To start, I'd say it's quite a strong indicator that 86% of our business — our domestic business — is expanding at 13%. That speaks, beneath the surface, to the growth tailwinds we see in the business and how well we can execute at that level. As we've talked about on earlier calls, during the past year we moved manufacturing for our international business to a contract manufacturer, and deliveries have slowed as we brought that contract manufacturer up to speed. Those kinds of issues are natural and typical when shifting into a relationship like that, and we anticipate resolving them across the coming couple of quarters. My view is that this is merely a short-term dip in deliveries. The business remains strong, demand tailwinds remain very strong, and our international backlog remains very strong. I regard this as only a temporary dip in our deliveries that we anticipate unwinding across the coming couple of quarters.
OK, that's clear. Could you give us some detail on what's fueling the impressive expansion in EW during this year? Is it right to view the emphasis as leaning more broadly toward COAs, or are other systems the main engines of that growth?
Like we mentioned before, what we're experiencing is expansion and rising need that is genuinely wide-ranging; it truly spans our entire portfolio, and we are encountering greater demand. I would not restrict what I say to just one specific segment. Demand signals are coming in strong everywhere.
Great. Thanks, guys.
Hi, good afternoon. Great quarter. I was wondering if you could share your perspective on the revenue opportunity for CPA-based ruggedized servers, whether in terms of the growth rate or your target share of the total revenue mix. And do those ruggedized servers carry either higher or lower margins than some of the other weapon systems or programs?
Yeah, I don't think we've sized specifically what we see there. What I would say is, I'd echo Bill's comment. Over the course of the last year, we've seen very strong demand. We've talked about some of the larger awards and activities we have there. Earlier this quarter, we discussed the CTG activity we announced. It's performing well and exceeding our expectations at this stage, after we paused briefly to get things right and then began scaling up significantly, and you can see how the activity is distributed. We've mentioned before that a substantial portion would fall under the radar line item. We've discussed this, so when you look at the radar line item and its growth, you can consider much of that to be consistent with it. We don't discuss the margin profile of any individual product.
Even so, I'd note that it's quite thrilling on our end to observe that while our deliveries are going up, the pipeline is growing too.
Yeah.
We have a lot of fresh program possibilities coming into view, and a few might land pretty soon, which is really thrilling for the CPA segment. Once again, that's merely a single domain where we anticipate favorable momentum capable of supporting results beyond the guidance we gave. One more point regarding CPA: as we've mentioned previously, our engineering emphasis has been on boosting capability and achieving reduced sizes. Customer curiosity about those reduced sizes is now beginning to show up, and while it's still early days, it's quite thrilling to watch that begin to take shape, since I believe it unlocks an entirely new, extra TAM when it comes to reduced sizes able to work across various platforms — which might serve as yet another catalyst for our CPA segment, and that's genuinely exciting to witness.
Regarding those more compact designs, assuming you could install them on something mobile, such as an armored vehicle on the ground or an unmanned surface vessel, is there a chance to win business away from other network computing makers, for instance Leonardo DRS?
In my view, that represents a chance for us to gain share in places where security needs are essential. Since we are the sole supplier of CPA technology along with the security components built into it, that makes me quite optimistic about our ability to break into new markets with smaller form factors and land on more platforms.
I appreciate that thorough analysis — thank you.
Yes, thank you, Austin.
Hi there. Thanks for fielding the question. I wanted to ask whether you might share a bit more information about that memory-related agreement. How much did it matter when it came to bookings, and would that deal sit inside a normal margin compared with the remainder of the backlog?
Yeah, I don't believe we've sized any of those bookings. What I'd say is that it ranked among our bigger bookings for the year, a quarter, a booking spanning multiple years. I'd also say that this portion of our business generally operates toward the upper end of our margin profile. But beyond that, I think I'd stop there.
Right, and the one other point I'd make, Bill, is that here, clearly, since it shows up in our bookings, the customer is coming to us first.
Right.
And in that situation, what you're seeing from the customer is an acknowledgment of, look, we'd like to move on this sooner rather than later; we'd like to nail this down. Look, we'd like to partner with you, Mercury, to make it happen.
Right.
I'd say that perspective matters a lot, and it wasn't something we pulled off by ourselves. It came from collaborating with the customer group to make it happen.
Got it. And then, I realize you mentioned something regarding the overall strength of bookings being broad, but I'm curious whether any particular segments or end markets are disproportionately driving the longer length of these contracts and the growing assurance about partnerships spanning multiple years. Is it that area, or perhaps another sector, that you view as contributing to the extended duration as well?
Yes. What I would say is that across the company, we've observed a modest number of orders tied to multi-year arrangements. However, when it comes to the munitions contracts and the strategic frameworks covering multiple years, those remain possible tailwinds, since we're engaged in many discussions with customers whose agreements are already established, funding is beginning to come together, and it sits in our pipeline, yet it hasn't shown up in bookings. We've described those types of scenarios as potential tailwinds that, should they come through, could have a significant effect on our outlook; but as of now, none of them have come to fruition.
Sure, here's how I'd frame that: when it comes to those types of efforts, we've consistently noted that the probability is it happens further along in the calendar year. So once we reach Q1 and then Q2, that's the period when we anticipate having greater clarity on the matter. As Bill mentioned, at this moment we view them as tailwinds. None of that has been factored into the guidance we've provided.
Exactly.
The precise schedule for several of those items remains somewhat unclear. And beyond that, will it cover just one year? Or could it be an agreement spanning multiple years? Each of those options has been put forward by us because our customer asked for them, and at this point we're simply collaborating with them so that final decisions on those matters can be reached.
Really appreciate the color. Thank you.
Yep.
All right. Thanks, Percy. With that, I think we can wrap up the call. I appreciate everyone spending time with us this evening, and I look forward to reconnecting next quarter.
This concludes today's call. Thank you for attending. You may now disconnect
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Mercury Systems, Inc. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Mercury Systems, Inc. earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.